AIP
SRRA

Ameritas Investment Partners’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Ameritas Investment Partners’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,111
Closed -$61K – 3073
2022
Q2 		$61K Buy
+1,111
New +$58.3K ﹤0.01% 1864

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Ameritas Investment Partners's SRRA Position: Q3 2022 in Review

Ameritas Investment Partners sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 1,111 shares — an estimated $61K sold.

Ameritas Investment Partners first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $61K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Ameritas Investment Partners reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,111 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $61K.
  • Ameritas Investment Partners first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Ameritas Investment Partners's Sierra Oncology, Inc. Common Stock position peaked at $61K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Ameritas Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.